Revolution MD (Equity)

Funding Details
Awarder
StartEngine
Date Award
July 29, 2022
Vertical
Biotech
Funding URL
View Funding Page
Valuation
$26,710,000

Company Info
Founding Year
2018
Traction
None
Organizations Involved
Center for Disease Control and Prevention
Founders
Josh Kimmel, Ken Greenwood, Mike Agentis
Company Description
Revolution MD has developed a solution to the opioid epidemic. Their patented Smart Inhaler combines biometric authentication with abuse deterrents in a proprietary blockchain network, aiming to prevent overdose and properly taper off medication as prescribed by physicians. The portable device is designed in collaboration with healthcare providers and supported by a team of pharmaceutical and regulatory experts.
Market
Healthcare
Location
Knoxville, TN, US
Coinvestors
StartEngine Capital, LLC

Links
Back to Home Back to Biotech Deals View Funding Announcement